by phymw | 1 Sep 2019
Iwan A. Burgener, Prof. Dr.med.vet., PhD, Dr. habil, Dipl. ACVIM & ECVIM-CA
Head of Small Animal Internal Medicine and Head of Small Animal Clinic VetMedUni Vienna
Professor Burgener received his veterinary degree, his Dr.med.vet. and his PhD from the University of Bern, Switzerland. His career since then included various academic posts at the universities of Bern (CH), Baton Rouge (LA, USA), Leipzig (D), and Utrecht (NL) before he moved to his current position as Professor and Chair of Small Animal Internal Medicine at the VetMedUni Vienna, Austria where he is also Head of the Small Animal Clinic. His research interests center around gastroenterology topics, and he has published over 60 articles in peer-reviewed journals and has written several book chapters on gastrointestinal tract, liver and pancreas.
Current ways to look at CE, breaking away from the past’s empirical approach.
Jan S. Suchodolski is an associate professor in small animal medicine, associate director for research, and head of microbiome sciences at the Gastrointestinal Laboratory at Texas A&M University. He received his DrVetMed from the University Vienna, Austria and his PhD in veterinary microbiology from Texas A&M University. He is also board certified in immunology by the American College of Veterinary Microbiologists (ACVM).
His research is focused on developing biomarkers for gastrointestinal disease and therapeutic approaches for the modulation of the intestinal microbiota. He has authored or co-authored more than 240 peer-reviewed articles in the area of veterinary gastroenterology and microbiome research.
Defining the microbiome in pets, ways to diagnose dysbiosis and the key differences in the human microbiome.
Dr. Curtis Huttenhower is a Professor in Biostatistics and Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health and an Associate Member at the Broad Institute. He co-directs the Harvard Chan Center for the Microbiome in Public Health and the HSPH Microbiome Analysis Core. He participated extensively in the NIH Human Microbiome Project and co-leads the “HMP2” Center for characterizing the gut microbial ecosystem in IBD and the Human Microbiome Bioactives Resource.
His lab focuses on methods for functional analysis of microbial communities in population health. This includes systems biology reconstructions integrating metagenomic, metatranscriptomic, and other microbial community ‘omics, the human microbiome in autoimmune disease such as IBD, and its potential as a biomarker and route for therapeutic intervention.
Key learnings from this exciting mega-project and details on the systematic effects from disturbances in the gut microbiome.